vs
Huron Consulting Group Inc.（HURN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Huron Consulting Group Inc.的1.4倍（$622.0M vs $442.0M），Royalty Pharma plc净利率更高（34.4% vs 6.9%，领先27.5%），Huron Consulting Group Inc.同比增速更快（10.7% vs 4.8%），过去两年Huron Consulting Group Inc.的营收复合增速更高（10.3% vs 4.6%）
休伦咨询集团是一家全球专业管理咨询服务提供商，深耕医疗健康、生命科学、商业企业及高等教育四大核心领域，为各行业客户定制适配业务发展的解决方案，助力客户优化运营效率、实现长期发展目标。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HURN vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.4倍
$442.0M
营收增速更快
HURN
高出5.9%
4.8%
净利率更高
RPRX
高出27.5%
6.9%
两年增速更快
HURN
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $442.0M | $622.0M |
| 净利润 | $30.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 11.4% | 62.4% |
| 净利率 | 6.9% | 34.4% |
| 营收同比 | 10.7% | 4.8% |
| 净利润同比 | -9.8% | 2.9% |
| 每股收益（稀释后） | $1.71 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HURNRPRX
| Q4 25 | $442.0M | $622.0M | ||
| Q3 25 | $441.3M | $609.3M | ||
| Q2 25 | $411.8M | $578.7M | ||
| Q1 25 | $404.1M | $568.2M | ||
| Q4 24 | $399.3M | $593.6M | ||
| Q3 24 | $378.1M | $564.7M | ||
| Q2 24 | $381.0M | $537.3M | ||
| Q1 24 | $363.4M | $568.0M |
净利润HURNRPRX
| Q4 25 | $30.7M | $214.2M | ||
| Q3 25 | $30.4M | $288.2M | ||
| Q2 25 | $19.4M | $30.2M | ||
| Q1 25 | $24.5M | $238.3M | ||
| Q4 24 | $34.0M | $208.2M | ||
| Q3 24 | $27.1M | $544.0M | ||
| Q2 24 | $37.5M | $102.0M | ||
| Q1 24 | $18.0M | $4.8M |
营业利润率HURNRPRX
| Q4 25 | 11.4% | 62.4% | ||
| Q3 25 | 11.3% | 70.1% | ||
| Q2 25 | 11.1% | 36.3% | ||
| Q1 25 | 8.1% | 94.0% | ||
| Q4 24 | 11.8% | 60.9% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 15.6% | 50.2% | ||
| Q1 24 | 5.5% | -13.0% |
净利率HURNRPRX
| Q4 25 | 6.9% | 34.4% | ||
| Q3 25 | 6.9% | 47.3% | ||
| Q2 25 | 4.7% | 5.2% | ||
| Q1 25 | 6.1% | 41.9% | ||
| Q4 24 | 8.5% | 35.1% | ||
| Q3 24 | 7.2% | 96.3% | ||
| Q2 24 | 9.8% | 19.0% | ||
| Q1 24 | 5.0% | 0.8% |
每股收益（稀释后）HURNRPRX
| Q4 25 | $1.71 | $0.49 | ||
| Q3 25 | $1.71 | $0.67 | ||
| Q2 25 | $1.09 | $0.07 | ||
| Q1 25 | $1.33 | $0.55 | ||
| Q4 24 | $1.82 | $0.46 | ||
| Q3 24 | $1.47 | $1.21 | ||
| Q2 24 | $2.03 | $0.23 | ||
| Q1 24 | $0.95 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.5M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $528.6M | $9.7B |
| 总资产 | $1.5B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HURNRPRX
| Q4 25 | $24.5M | $618.7M | ||
| Q3 25 | $23.9M | $938.9M | ||
| Q2 25 | $61.0M | $631.9M | ||
| Q1 25 | $23.4M | $1.1B | ||
| Q4 24 | $21.9M | $929.0M | ||
| Q3 24 | $18.5M | $950.1M | ||
| Q2 24 | $17.6M | $1.8B | ||
| Q1 24 | $18.6M | $843.0M |
总债务HURNRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益HURNRPRX
| Q4 25 | $528.6M | $9.7B | ||
| Q3 25 | $499.8M | $9.6B | ||
| Q2 25 | $475.0M | $9.5B | ||
| Q1 25 | $494.3M | $9.8B | ||
| Q4 24 | $561.3M | $10.3B | ||
| Q3 24 | $522.8M | $10.3B | ||
| Q2 24 | $500.6M | $9.8B | ||
| Q1 24 | $495.6M | $9.9B |
总资产HURNRPRX
| Q4 25 | $1.5B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.5B | $18.3B | ||
| Q1 25 | $1.4B | $17.6B | ||
| Q4 24 | $1.3B | $18.2B | ||
| Q3 24 | $1.3B | $18.0B | ||
| Q2 24 | $1.3B | $17.7B | ||
| Q1 24 | $1.3B | $16.1B |
负债/权益比HURNRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $123.8M | — |
| 自由现金流率自由现金流/营收 | 28.0% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 4.12× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $183.0M | — |
8季度趋势，按日历期对齐
经营现金流HURNRPRX
| Q4 25 | $126.4M | $827.1M | ||
| Q3 25 | $93.8M | $702.6M | ||
| Q2 25 | $80.0M | $364.0M | ||
| Q1 25 | $-106.8M | $596.1M | ||
| Q4 24 | $139.6M | $742.5M | ||
| Q3 24 | $85.2M | $703.6M | ||
| Q2 24 | $107.2M | $658.2M | ||
| Q1 24 | $-130.7M | $664.6M |
自由现金流HURNRPRX
| Q4 25 | $123.8M | — | ||
| Q3 25 | $89.8M | — | ||
| Q2 25 | $78.0M | — | ||
| Q1 25 | $-108.7M | — | ||
| Q4 24 | $137.0M | — | ||
| Q3 24 | $82.8M | — | ||
| Q2 24 | $104.7M | — | ||
| Q1 24 | $-131.9M | — |
自由现金流率HURNRPRX
| Q4 25 | 28.0% | — | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | -26.9% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 27.5% | — | ||
| Q1 24 | -36.3% | — |
资本支出强度HURNRPRX
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.3% | — |
现金转化率HURNRPRX
| Q4 25 | 4.12× | 3.86× | ||
| Q3 25 | 3.08× | 2.44× | ||
| Q2 25 | 4.12× | 12.06× | ||
| Q1 25 | -4.35× | 2.50× | ||
| Q4 24 | 4.11× | 3.57× | ||
| Q3 24 | 3.14× | 1.29× | ||
| Q2 24 | 2.86× | 6.45× | ||
| Q1 24 | -7.26× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HURN
| Consulting And Managed Services Capability | $172.9M | 39% |
| Education | $118.7M | 27% |
| Commercial | $91.9M | 21% |
| Digital Capability | $54.6M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
